Protocol for evaluating neuronal activity and neurotransmitter release following amyloid-beta oligomer injections into the rat hippocampus
STAR Protoc (2025) 6 (2), 103712 DOI: 10.1016/j.xpro.2025.103712
Network pharmacology and metabolomics analysis of Tinospora cordifolia reveals BACE1 and MAOB as potential therapeutic targets for neuroprotection in Alzheimer’s disease
Sci Rep (2025) 15 (1), 8103 DOI: 10.1038/s41598-025-92756-5
Hydromethylthionine sustains truncated tau-dependent inflammation-lowering effects in mouse brain
FEBS J (2025). DOI: 10.1111/febs.70021
Age-associated microglial transcriptome leads to diminished immunogenicity and dysregulation of MCT4 and P2RY12/P2RY13 related functions
Cell Death Discov (2025) 11 (1), 16 DOI: 10.1038/s41420-025-02295-1
Recursive seed amplification detects distinct α-synuclein strains in cerebrospinal fluid of patients with Parkinson's disease
Acta Neuropathol Commun (2025) 13 (1), 13 DOI: 10.1186/s40478-024-01923-8
Autoantibodies against α-synuclein inhibit its aggregation and cytotoxicity
J Autoimmun (2025) 152, 103390 DOI: 10.1016/j.jaut.2025.103390
A nanoparticle-based wireless deep brain stimulation system that reverses Parkinson’s disease
Sci Adv (2025) 11 (3), eado4927 DOI: 10.1126/sciadv.ado4927
CD22 modulation alleviates amyloid β-induced neuroinflammation
J Neuroinflammation (2025) 22 (1), 32 DOI: 10.1186/s12974-025-03361-2
The tau isoform 1N4R confers vulnerability of MAPT knockout human iPSC-derived neurons to amyloid beta and phosphorylated tau-induced neuronal dysfunction
Alzheimers Dement (2025) DOI:10.1002/alz.14403
Ultrasensitive and Multiple Biomarker Discrimination for Alzheimer's Disease via Plasmonic & Microfluidic Sensing Technologies
Advanced Science (2024), Vol 11 (24), https://doi.org/10.1002/advs.202308783